| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1968540 | Clinical Biochemistry | 2016 | 4 Pages |
•Amylase can be considered as a tumor marker reflecting response to chemotherapy and disease relapse.•Amylase mRNA from lung cancer was transcribed from salivary type gene, indicated that lung cancer cells can produce salivary type amylase, rather than the more common type of pancreatic amylase.•We should consider malignancy-associated hyperamylasemia when pancreatic lesions have been excluded.
ObjectivesTo assess the relationship between amylase level and small cell lung cancer in a patient with hyperamylasemia of non-pancreatic disease.Design and MethodsCase report with correlation analysis between hyperamylasemia and small cell lung cancer while considering immunohistochemistry study and response to chemotherapy.ResultsWe observed a strong correlation between amylase levels and small cell lung cancer. Immunohistochemistry findings suggested that amylase was produced by the lung cancer in this case.ConclusionsAmylase can be considered as a tumor marker reflecting response to chemotherapy and disease relapse.
